Gemcitabine hydrochloride
NDC 82511-008, Gemcitabine hydrochloride, injection, powder, lyophilized, for solution, from Teyro Labs Private Limited.
- Product NDC
- 82511-008
- Status
- Listed
- Labeler
- Teyro Labs Private Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078759
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82511-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMCITABINE HYDROCHLORIDE200 mg/5mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82511-008-20 | 82511000820 | 1 VIAL, SINGLE-USE in 1 CARTON (82511-008-20) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a6ddaa2f-4c17-430f-a7cd-96b6662923f6
Use it
Look up 82511-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82511-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82511-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.